Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1127 | Endocrine tumours | ECE2015

Expression of ghrelin and somatostatin systems components in pancreatic neuroendocrine tumours and their relationship with clinical-histological characteristics

Herrera-Martinez Aura D , Gahete Manuel , Sanchez-Sanchez Rafael , Cuenca Teresa Caro , Blanch Raquel Serrano , Luque Raul , Moreno Maria A Galvez , Castano Justo

Pancreatic neuroendocrine tumors (PNETs) are uncommon neoplasms from the endocrine pancreas, whose incidence is recently rising. Unfortunately, an advanced stage is often found at diagnosis; thus, identification of new molecular diagnostic, prognostic, and therapeutic markers is required. Ghrelin and somatostatin/cortistatin systems are two multifunctional regulatory complexes widely distributed throughout multiple tissues, including the pancreas, where they exert diverse (pat...

ea0056p133 | Endocrine tumours and neoplasia | ECE2018

Presence and functional role of KiSS/KiSS-R system in pancreatic neuroendocrine tumors (panNETs) and its relationship with clinical features and tumor behavior

Alors-Perez Emilia , Pedraza-Arevalo Sergio , Herrera-Martinez Aura , Diaz-Perez Angel J , Caro Teresa , Serrano-Blanch Raquel , Sanchez-Sanchez Rafael , Galvez-Moreno Maria Angeles , Castano-Fuentes Justo P , Luque Raul M , Martinez-Fuentes Antonio J

Pancreatic neuroendocrine tumors (panNETs) are the second most common neoplasm of the pancreas. panNETs arise from cells of the pancreatic islets and comprise a diverse and heterogeneous group of neoplasms. This hampers their systematic study, and the identification of common molecular signatures that might facilitate a better diagnosis of the disease, and the development of efficient therapeutic approaches. Indeed, there are no clinical, biochemical, anatomopathological, immu...

ea0049ep443 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Prevalence of hyperglycemia in patients hospitalized in the health area of cuenca (Spain)

Perez-Rodriguez Jose , Guerra-Navarro Lidia , Alramadan Mubarak , Garcia-Notario Paula , Martin-Iglesias David , Aranda-Regules Santiago , Calderon-Vicente Dulce

Introduction and objectives: Hyperglycemia is a common problem in hospitalized patients, that increases infections, mortality, costs and the hospital stay. The objective of this study is to know the prevalence of hyperglycemia in our hospital.Methods: We designed a cross-sectional observational study. We included patients admitted in the hospital every 3 days in 2 months. We excluded patients younger than 15 years, stays less than 3 days and those of the...

ea0049ep524 | Diabetes complications | ECE2017

Comorbilities and morbimortality of patients with hospital hyperglycemia in the health area of Cuenca (Spain)

Perez-Rodriguez Jose , Calderon-Vicente Dulce , Aranda-Regules Santiago , Guerra-Navarro Lidia , Garcia-Notario Paula , Alramadan Mubarak , Martin-Iglesias David

Introduction and objectives: Hyperglycemia (HG) is a common problem in hospitalized patients that increases infections, mortality, costs and the hospital stay. The objective of this study is to know the association of the HG with cardiovascular risk factors (CVRF), stress factors, hospital stay and mortality.Methods: We designed a cross-sectional observational study. We included patients admitted in the hospital every three days in two months. We exclude...

ea0049ep524 (1) | Diabetes complications | ECE2017

Comorbilities and morbimortality of patients with hospital hyperglycemia in the health area of Cuenca (Spain)

Perez-Rodriguez Jose , Calderon-Vicente Dulce , Aranda-Regules Santiago , Guerra-Navarro Lidia , Garcia-Notario Paula , Alramadan Mubarak , Martin-Iglesias David

Introduction and objectives: Hyperglycemia (HG) is a common problem in hospitalized patients that increases infections, mortality, costs and the hospital stay. The objective of this study is to know the association of the HG with cardiovascular risk factors (CVRF), stress factors, hospital stay and mortality.Methods: We designed a cross-sectional observational study. We included patients admitted in the hospital every three days in two months. We exclude...

ea0049ep593 | Diabetes therapy | ECE2017

Management and control of hospital hyperglycemia in the health area of cuenca (Spain)

Perez-Rodriguez Jose , Garcia-Notario Paula , Martin-Iglesias David , Guerra-Navarro Lidia , Alramadan Mubarak , Aranda-Regules Santiago , Calderon-Vicente Dulce

Introduction and objectives: Hyperglycemia is a common problem in hospitalized patients that increases infections, mortality, costs and the hospital stay. The objective of this study is to know the management and control of hyperglycemia in our hospital.Methods: We designed a cross-sectional observational study. We included patients admitted in the hospital every three days in two months. We excluded patients younger than 15 years, stays less than three ...

ea0029p1805 | Thyroid cancer | ICEECE2012

Differentiated thyroid cancer and hemodialysis: Long-term outcomes and safety after radioiodine use.

Navarro Gonzalez E. , Martinez Ortega A. , Guerrero Vazquez R. , Martinez Brocca M. , Cuenca Cuenca J.

Introduction: The use of radioiodine is a common treatment for differentiated thyroid cancer. However, special care should be exercised in treating patients who are on hemodialysis, due to the renal elimination of the radionuclide, which implies several technical difficulties and safety concerns. We have previously described the procedure and the short-term outcome and safety in three patients (Jimenez et al, Thyroid 2001; 11(11):1031–1034). Our results showed that the ra...

ea0057017 | Evaluation of knowledge regarding gestational diabetes and evaluation of (group) education for gestational diabetes: the ELENA study | BES2018

Evaluation of knowledge regarding gestational diabetes and evaluation of (group) education for gestational diabetes: the ELENA study

Caro Minschart , Chantal Mathieu , Katrien Benhalima

Background and aims: The prevalence of gestational diabetes (GDM) increases worldwide with rates between 9 and 35%. The management of GDM is a labor-intensive discipline, in which the global increase in GDM prevalence poses challenges to maintain high-quality care. A valuable solution could be the organization of group education. The ELENA study therefore aimed to evaluate women’s satisfaction about (group) education and treatment, their knowledge about GDM and whether th...

ea0073pep9.6 | Presented ePosters 9: Endocrine-Related Cancer | ECE2021

Characterization of signaling pathways and molecular mechanisms underlying kisspeptin response in pancreatic neuroendocrine tumor (panNETs) cells

Antonio C Fuentes-Fayos , Emilia Alors-Pérez , Sergio Pedraza Arévalo , Aura D. Herrera-Martínez , Jose Angel Días-Pérez , Teresa Caro , MARIA Angeles Galvez Moreno , Raul M Luque , Antonio Jesús Martínez-Fuentes

Pancreatic neuroendocrine tumors (panNETs) comprise several neoplasms in which a precise diagnosis and therapeutic treatment are hampered by their diversity and heterogeneity which in turn, hind the identification of common molecular signatures and the development of efficient therapeutic approaches. Subsequently, there are no clinical, biochemical, anatomopathological, immunohistochemical or molecular features capable to currently predict either tumor prognosis or post-surgic...

ea0073oc9.3 | Oral Communications 9: Endocrine-Related Cancer | ECE2021

Dysregulation of alternative splicing unveils new avenues for targeting pulmonary carcinoids

Blázquez-Encinas Ricardo , Teresa Caro María , García-Vioque Víctor , Pedraza-Arévalo Sergio , Alors-Pérez Emilia , Dulcínea Herrera-Martínez Aura , Sánchez-Sánchez Rafael , Serrano-Blanch Raquel , Foll Matthieu , Fernández-Cuesta Lynnette , D Gahete Manuel , M Luque Raúl , Ibáñez-Costa Alejandro , P Castaño Justo

IntroductionDysregulation of alternative splicing is emerging as a new hallmark of cancer. This dysregulation may originate from mutations and/or altered expression of specific components of the splicing machinery. Indeed, our group has shown that the expression profile of the splicing machinery is altered in several types of cancer, including endocrine-related cancers. However, to date, the status of alternative splicing and its putative dysregulation h...